Therefore, we think that the value of 5.49 for AFP in our study, which aims to diagnose cirrhosis patients with CHC only with a high number of patients and takes DAA therapy into account, is a very important auxiliary cut‐off for decision‐makers. The gene discussed is AFP; the disease is Cirrhosis.